Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 6, 2021

Primary Completion Date

May 25, 2022

Study Completion Date

May 25, 2022

Conditions
Vestibular Schwannoma
Interventions
DRUG

Fluorescein Sodium

Intravenous administration 1 mg/kg initial dosing if insufficient additional doses of 1 mg/kg may be administered.

DEVICE

YELLOW560 filter

Integrated fluorescence module serves to make fluorescent areas visible to assist in visualizing tumor during the resection.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04351373 - Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560 | Biotech Hunter | Biotech Hunter